Is high-quality, real-world evidence being used to inform health care decision-making? In the "real world," patients have characteristics and treatment experiences that often differ from the controlled environment of clinical studies. NPC's research has examined how decision-makers view this evidence and the challenges to its broader use.
Do decision-makers know what “good” looks like? Good data and widely agreed upon research methods must be the basis for developing and appraising high-quality, real-world evidence. NPC’s work answers these questions, and offers online training, tools and checklists to evaluate real-world evidence.
Why is broader access to real-world evidence data important? Whom does it benefit? What challenges remain? NPC takes a closer look at the limitations that can make it harder to conduct high-quality, real-world studies, and offers ways to reduce barriers to access while addressing privacy issues.
It's important for all stakeholders to work together to better understand and communicate complex data about how treatments work in the real world. What are the constraints to sharing evidence? Who is allowed to talk about the evidence, and when? NPC's work addresses the existing barriers to communicating evidence, and considers changes to the U.S. Food and Drug Administration's current, ambiguous regulations.